Ziyu Yang

Ziyu Yang

Auto-generated profile, based on publicly available information

Ziyu Yang

Vascular Biology and Therapeutics Program, Yale University, New Haven, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2024 in Nature Cardiovascular Research
Verified
Journal Article
Open access
PDF file
DJDivyesh Joshi
Divyesh Joshi
BCBrian G. Coon
Brian G. Coon
RCRaja Chakraborty
Raja Chakraborty
HDHanqiang Deng
Hanqiang Deng
ZYZiyu Yang
Ziyu Yang
MSMartin Alexander Schwartz
Martin Alexander Schwartz
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of mortality worldwide. Laminar shear stress from blood flow, sensed by vascular endothelial cells, protects from ASCVD by upregulating the transcription factors KLF2 and KLF4, which induces an anti-inflammatory program that promotes vascular resilience. Here we identify clustered γ-protocadherins as therapeutically targetable, potent KLF2 and KLF4 suppressors whose upregulation contributes to ASCVD. Mechanistic studies show that γ-protocadherin cleavage results in translocation of the conserved intracellular domain to the nucleus where it physically associates with and suppresses signaling by the Notch intracellular domain. γ-Protocadherins are elevated in human ASCVD endothelium; their genetic deletion or antibody blockade protects from ASCVD in mice without detectably compromising host defense against bacterial or viral infection. These results elucidate a fundamental mechanism of vascular inflammation and reveal a method to target the endothelium rather than the immune system as a protective strategy in ASCVD.